ACE2 and COVID-19: Extremely high levels of angiotensin-converting enzyme 2 (ACE2) have been seen in many different kinds of cancer cells, including lung adenocarcinoma (LUAD) and lung squamous carcinoma (LUSC), suggesting a link between COVID-19 and the progression of cancer and the mortality rate [70].